SAN DIEGO , July 25, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, will release financial results for the quarter ended June 30, 2023 , before the market open on Monday, August 7, 2023 . John Aballi , Exagen’s President and Chief Executive